CB Therapeutics is making psychedelic compounds (tryptamines, cannabinoids, and more) from yeast. Through bioreactor fermentation, the company hopes to capture a large part of the production of psychedelics market.
CB Therapeutics
The company aims to provide psychedelic compounds for the treatment of mental health disorders. The production process, growing them in yeast, allows them to do it at scale and efficiency not found elsewhere in nature.
“We Are Advancing Fermentation-based Cellular Agriculture and Neuroscience to Achieve Breakthroughs in Mental Healthcare“
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates